| 111.43 BATS BZX Real-Time Price As of 1:39pm ET |  -0.72 / -0.64%Today’s Change | 101.36 Today|||52-Week Range 132.13 | -3.71% Year-to-Date |
| 3 Top Diabetes Stocks to Watch in November Nov 07 / MotleyFool.com - Paid Partner Content | Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buy Nov 06 / MotleyFool.com - Paid Partner Content |
| Previous close | 112.15 |
| Today’s open | 112.02 |
| Day’s range | 111.26 - 112.32 |
| Volume | 1,223,276 |
| Average volume (3 months) | 3,509,755 |
| Market cap | $109.0B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +4.19% |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | +7.36% |
| P/E ratio | 24.7 |
| Price/Sales | 4.87 |
| Price/Book | 12.21 |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | -0.39 | -0.89% |
| NVONovo Nordisk | +0.25 | +0.43% |
| SNYSanofi | -0.50 | -1.10% |
| BMYBristol-Myers Squibb | -0.39 | -0.66% |
| Next reporting date | January 30, 2020 |
| EPS forecast (this quarter) | $1.50 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 13.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
